ANN FIORESI: Open Payments
NPI 1801808936 · ROSLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$273 in 13 payments from 8 companies in 2025. Trend: 2023 $430 · 2024 $374 · 2025 $273
Food & beverage: $273
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $73 |
| Novartis Pharmaceuticals Corporation | 3 | $52 |
| Amgen Inc. | 2 | $36 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $30 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $27 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $25 |
| AstraZeneca Pharmaceuticals LP | 1 | $16 |
| Esperion Therapeutics, Inc. | 1 | $14 |
Products named: LEQVIO, JOURNAVX, Wegovy, JARDIANCE, Kerendia, Ozempic, Rybelsus, REPATHA.
Industry payments across NY — which companies pay providers there.
